Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.10
-0.12 (-0.52%)
At close: Sep 16, 2026, 4:00 PM EDT
23.28
+0.18 (0.78%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.31 billion as of September 16, 2026. Its market cap has increased by 10.37% in one year.
Market Cap
2.31B
Enterprise Value
1.40B
1-Year Change
10.37%
Ranking
Category
Stock Price
$23.10
ChartMarket Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.31B, an increase of 603.80%. That is a compound annual growth rate of 34.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 2.31B | -15.63% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Precigen | 2.48B |
| Viridian Therapeutics | 2.44B |
| Harmony Biosciences Holdings | 2.42B |
| Vera Therapeutics | 2.41B |
| Ocular Therapeutix | 2.28B |
| SELLAS Life Sciences Group | 2.27B |
| Nektar Therapeutics | 2.26B |
| Sarepta Therapeutics | 2.21B |